Office of Research & Development |
![]() ![]() |
Project Number: | I01BX000282-09A2 |
Title: | PCSK9-A novel target for the treatment of myocardial ischemia |
Principal Investigator: | Jawahar L. Mehta |
Location: | Little Rock, AR |
Congressional District Code: | 2 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2019 - March 2023 |
FY 2021 Funding Amount: | $156,800 |
Total Award Amount (all years): |
$782,780 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Mainly expressed in liver, kidney and small intestine, the enzyme proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low-density lipoprotein-cholesterol receptor (LDLr), and causes degradation of LDLs. Although not proven, it has been suggested that these agents may reduce cardiovascular events. Recent work from our group shows that besides the liver, kidney and small intestine, cardiomyocytes also express PCSK9. The secretion of PCSK9 increases during ischemia by >10 fold. PCSK9... |